Trial Profile
PHASE II TRIAL OF SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH CAPECITABINE PLUS INTERFERON ALPHA2a FOLLOWED BY IL-2 IN PATIENTS WITH METASTATIC KIDNEY CANCER.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2011
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Interferon alpha-2a; Interleukin-2
- Indications Renal cancer
- Focus Therapeutic Use
- 26 Jul 2011 New trial record